sulfur hexafluoride has been researched along with Hemorrhage, Vitreous in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (7.69) | 18.7374 |
1990's | 2 (15.38) | 18.2507 |
2000's | 5 (38.46) | 29.6817 |
2010's | 3 (23.08) | 24.3611 |
2020's | 2 (15.38) | 2.80 |
Authors | Studies |
---|---|
Rosales, CR; Rush, RB; Rush, SW; Velazquez, JC | 1 |
Bhattacharjee, H; Javeri, H | 1 |
Chao, AN; Chen, KJ; Chen, TL; Kuo, YH; Lai, CC; Liu, L; Wu, WC; Yang, KJ; Yeung, L | 1 |
Gotoh, N; Hasegawa, T; Ooto, S; Otani, A; Sasahara, M; Tamura, H; Tsujikawa, A; Yamashiro, K; Yoshimura, N | 1 |
Chiang, A; DeCroos, FC; Garg, SJ; Hsu, J; Khuthaila, MK; Milder, EA; Setlur, V; Spirn, MJ | 1 |
Hoffmann, EM; Schwenn, O | 1 |
Acar, N; Altan, T; Kapran, Z; Ozdogan, S; Unver, YB | 1 |
Devenyi, RG | 1 |
Conway, MD; Peyman, GA; Recasens, M | 1 |
Kokame, GT | 1 |
Apostolopoulos, MN; Chatzoulis, DZ; Koutsandrea, CN; Parikakis, EA; Theodossiadis, GP | 1 |
Chen, SN; Ho, CL; Ho, JD; Kuo, YH | 1 |
Abi-Rached, J; Haut, J; Larricart, P; Vachet, JM; van Effenterre, G | 1 |
3 trial(s) available for sulfur hexafluoride and Hemorrhage, Vitreous
Article | Year |
---|---|
Gas Tamponade for the Prevention of Postoperative Vitreous Hemorrhaging After Diabetic Vitrectomy: A Randomized Clinical Trial.
Topics: Diabetes Mellitus; Diabetic Retinopathy; Humans; Sulfur Hexafluoride; Visual Acuity; Vitrectomy; Vitreous Hemorrhage | 2022 |
Hemostatic effects of SF6 after diabetic vitrectomy for vitreous hemorrhage.
Topics: Adult; Aged; Aged, 80 and over; Cataract; Diabetic Retinopathy; Female; Hemostasis; Hemostatic Techniques; Humans; Intraocular Pressure; Male; Middle Aged; Prospective Studies; Recurrence; Sulfur Hexafluoride; Visual Acuity; Vitrectomy; Vitreous Body; Vitreous Hemorrhage | 2001 |
Gas tamponade as a single technique in the treatment of retinal detachment: is vitrectomy needed? A comparative study of 120 cases.
Topics: Cataract; Clinical Trials as Topic; Cryosurgery; Gases; Humans; Ocular Hypertension; Retinal Detachment; Sulfur Hexafluoride; Vitrectomy; Vitreous Hemorrhage | 1987 |
10 other study(ies) available for sulfur hexafluoride and Hemorrhage, Vitreous
Article | Year |
---|---|
Evanescent gas-induced reversible lenticular opacity.
Topics: Cataract; Endotamponade; Humans; Lens, Crystalline; Male; Middle Aged; Postoperative Complications; Retinal Detachment; Sulfur Hexafluoride; Vitrectomy; Vitreous Hemorrhage | 2020 |
Reducing the incidence of early postoperative vitreous haemorrhage by preoperative intravitreal bevacizumab in vitrectomy for diabetic tractional retinal detachment.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Combined Modality Therapy; Diabetic Retinopathy; Female; Fluorocarbons; Follow-Up Studies; Humans; Incidence; Intravitreal Injections; Male; Middle Aged; Postoperative Complications; Preoperative Care; Retinal Detachment; Retrospective Studies; Sulfur Hexafluoride; Vascular Endothelial Growth Factor A; Visual Acuity; Vitrectomy; Vitreous Hemorrhage | 2010 |
Prognostic factors of vitreous hemorrhage secondary to exudative age-related macular degeneration.
Topics: Aged; Aged, 80 and over; Exudates and Transudates; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Lens Implantation, Intraocular; Macular Degeneration; Male; Middle Aged; Phacoemulsification; Photochemotherapy; Prognosis; Retrospective Studies; Sulfur Hexafluoride; Tomography, Optical Coherence; Visual Acuity; Vitrectomy; Vitreous Hemorrhage | 2010 |
Postoperative vitreous hemorrhage after diabetic 23-gauge pars plana vitrectomy.
Topics: Adult; Aged; Aged, 80 and over; Diabetic Retinopathy; Endotamponade; Female; Fluorocarbons; Follow-Up Studies; Humans; Laser Coagulation; Male; Microsurgery; Middle Aged; Postoperative Complications; Reoperation; Retrospective Studies; Risk Factors; Sulfur Hexafluoride; Visual Acuity; Vitrectomy; Vitreous Hemorrhage | 2013 |
[Heterochromia of the Iris after t-PA and Gas Injection of Sulfur Fluoride].
Topics: Aged; Aged, 80 and over; Choroidal Neovascularization; Female; Follow-Up Studies; Fundus Oculi; Humans; Iridocyclitis; Macula Lutea; Pigment Epithelium of Eye; Postoperative Complications; Reoperation; Retinal Hemorrhage; Sulfur Hexafluoride; Vitrectomy; Vitreous Hemorrhage | 2004 |
Early postoperative hypotony after 25-gauge sutureless vitrectomy with straight incisions.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorocarbons; Follow-Up Studies; Humans; Intraocular Pressure; Male; Microsurgery; Middle Aged; Ocular Hypotension; Postoperative Complications; Retinal Diseases; Retrospective Studies; Sulfur Hexafluoride; Suture Techniques; Vitrectomy; Vitreous Hemorrhage | 2008 |
Outpatient postvitrectomy fluid-gas exchange using long-acting gasses.
Topics: Ambulatory Care; Female; Fluorocarbons; Humans; Laser Coagulation; Male; Postoperative Care; Retinal Detachment; Sulfur Hexafluoride; Vitrectomy; Vitreoretinopathy, Proliferative; Vitreous Hemorrhage | 1995 |
Intravitreal tPA and SF6 promote clearing of premacular subhyaloid hemorrhages in shaken and battered baby syndrome.
Topics: Battered Child Syndrome; Female; Fibrinolytic Agents; Fundus Oculi; Humans; Infant; Injections; Macula Lutea; Male; Recombinant Proteins; Sulfur Hexafluoride; Tissue Plasminogen Activator; Vitreous Body; Vitreous Hemorrhage | 1999 |
Vitreous hemorrhage after intravitreal tissue plasminogen activator (t-PA) and pneumatic displacement of submacular hemorrhage.
Topics: Aged; Aged, 80 and over; Aneurysm; Female; Fibrinolytic Agents; Humans; Injections; Macula Lutea; Male; Retinal Artery; Retinal Hemorrhage; Sulfur Hexafluoride; Tissue Plasminogen Activator; Vitrectomy; Vitreous Hemorrhage | 2000 |
Intravitreous tissue plasminogen activator injection and pneumatic displacement in the management of submacular hemorrhage complicating scleral buckling procedures.
Topics: Adult; Aged; Female; Fibrinolytic Agents; Humans; Injections; Macula Lutea; Male; Middle Aged; Prone Position; Recombinant Proteins; Retinal Hemorrhage; Scleral Buckling; Sulfur Hexafluoride; Tissue Plasminogen Activator; Treatment Outcome; Visual Acuity; Vitreous Body; Vitreous Hemorrhage | 2001 |